Skip to Content

Clinical Trials Details

SWOG S1207

Patient Information

SWOG S1207 - Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive AND HER2/neu Negative Breast Cancer e3 Breast Cancer Study- evaluating everolimus with endocrine therapy

Learn more information about clinical trial - SWOG S1207.

Study Number
SWOG S1207

Clinical Trial Categories

  • Breast Cancer - Adjuvant


  • Cone Health Cancer Center
    501 N Elam Ave
    Greensboro, NC 27403-1199
    Main: 336-832-1100
    Fax: 336-832-0794

Also in this Section